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Objective: The objective of this retrospective study was to develop and validate a simple diagnostic prediction model by 
using ultrasound (US) features of thyroid nodules obtained from multicenter retrospective data.
Materials and Methods: Patient data were collected from 20 different institutions and the data included 2000 thyroid 
nodules from 1796 patients. For developing a diagnostic prediction model to estimate the malignant risk of thyroid nodules 
using suspicious malignant US features, we developed a training model in a subset of 1402 nodules from 1260 patients. 
Several suspicious malignant US features were evaluated to create the prediction model using a scoring tool. The scores for 
such US features were estimated by calculating odds ratios, and the risk score of malignancy for each thyroid nodule was 
defined as the sum of these individual scores. Later, we verified the usefulness of developed scoring system by applying 
into the remaining 598 nodules from 536 patients.
Results: Among 2000 tumors, 1268 were benign and 732 were malignant. In our multiple regression analysis models, the 
following US features were statistically significant for malignant nodules when using the training data set: 
hypoechogenicity, marked hypoechogenicity, non-parallel orientation, microlobulated or spiculated margin, ill-defined 
margins, and microcalcifications. The malignancy rate was 7.3% in thyroid nodules that did not have suspicious-malignant 
features on US. Area under the receiver operating characteristic (ROC) curve was 0.867, which shows that the US risk score 
help predict thyroid malignancy well. In the test data set, the malignancy rates were 6.2% in thyroid nodules without 
malignant features on US. Area under the ROC curve of the test set was 0.872 when using the prediction model.
Conclusion: The predictor model using suspicious malignant US features may be helpful in risk stratification of thyroid nodules.
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thyroid nodules. Participants of the meetings were selected 
among the members of the KSThR, which had more than 
5-years of experience in thyroid imaging. All participants 
acknowledged the importance of developing the TIRADS. 
During the meetings, discussion was focused on 2 topics: 
first, the inclusion criteria, and second, the US features 
to be analyzed in this study. The participants came to a 
consensus through majority voting.
 
Study Population
Patient data were collected from 20 radiologists based 
at 12 hospitals (9 university-affiliated hospitals and 3 
hospitals). Several aspects were considered in calculating 
an adequate sample size in forming a predicted model 
using US features of thyroid nodules. First, 18 US features 
were considered in constructing a prediction model during 
logistic regression based on the study by Moon et al. (11). 
Second, we assumed that the prevalence of malignancy on 
fine-needle aspiration (FNA) to be 16% (11). Third, since 
prediction models need validation, our data was split into 
2 sets; a training set for model building (70% of the total 
data included), and a test set for validation (30%). Based 
on these factors, we calculated more than 1600 nodules 
were required to power for statistical appropriateness of 
this study. According to these calculations, which were 
discussed during the each conference, each participating 
radiologist agreed to contribute at least 100 consecutive 
thyroid nodules for this multicenter study; the requirements 
for a contributing nodule which were: 1) equal or more than 
5 mm in the longest diameter on US, and 2) had undergone 
US-FNA in their institution during the study period during 
which the data was to have been gathered, which was 
between January 2007 and December 2008. Finally, this 
study included 2000 thyroid nodules in 1796 patients. Of 
the 2000 nodules, 1268 (63.4%) were benign and 732 
(36.6%) were malignant. If any of the participants were 
affiliated with the same institution, subsequent data were 
collected to avoid data overlap. Patients included in this 
study had to meet one or more of the following criteria: 
1) patients who underwent thyroid surgery regardless of 
cytologic results, 2) patients who had benign results on 
cytology at least twice, and 3) patients who had benign 
results on cytology and showed no change or decreased 
size at follow-up US for at least a year. The increase in size 
was defined as more than a 50% increase in volume or more 
than a 20% increase in at least 2 dimensions that show at 
least a 2 mm increase in solid nodules or the solid portion 
INTRODUCTION
Ultrasound (US) is the best diagnostic choice in the 
initial evaluation of thyroid nodules. Although US is an 
operator-dependent diagnostic tool, several reports show 
relatively good interobserver agreement in reaching a final 
assessment for thyroid nodules (1-4). Recently, the thyroid 
imaging reporting and data system (TIRADS) was developed 
in several studies to be used in risk stratification of thyroid 
nodules using various US features (5-8). Similar to TIRADS, 
there are several reporting systems in other medical fields, 
such as Breast Imaging Reporting and Data System (BI-
RADS) for evaluating breast lesions and the Bethesda 
system for examining the cytology of a thyroid nodule (9, 
10). The goal of these reporting systems is standardization 
and simplification of the reports, allowing effective 
communication between the reporting doctors, such as 
radiologists, cytologists, and clinicians (9, 10).
Although the TIRADS system has been demonstrated 
in several studies, the system used in each study lacked 
reproducibility, because each was developed based on the 
individual institution (5-8). Several factors, such as the use 
of different US equipment, different US criteria in assessing 
thyroid nodules, as well as the inevitable interobserver 
variability among radiologists, can have an effect on the 
final assessment of thyroid nodules. However, the various 
TIRADS systems that have been reported are not capable 
of considering these factors. The purpose of this study was 
to develop and to validate a simple diagnostic prediction 
model using features of thyroid nodules found on US and 
based on multicenter retrospective data.
MATERIALS AND METHODS
The institutional review board approval was obtained 
from all participating institutions for this retrospective 
study; due to the nature of the study, the informed consent 
requirement was waived.
Study Preparations
On 23 January 2011 and 11 March 2011, radiologists 
of the Korean Society of Thyroid Radiology (KSThR) held 
meetings to develop a consensus on the study design 
and population. While many US features were considered 
by the participating radiologists, these conferences were 
convened to develop a TIRADS to categorize thyroid 
nodules in order to stratify the risk of malignancy in 
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in mixed nodules (12, 13).  
Imaging and Imaging Analyses
Ultrasound images were taken using various US machines 
with high frequency linear array transducer for the 
evaluation of thyroid nodules. The scanning protocol in 
all cases included both transverse and longitudinal real-
time imaging of the thyroid nodules, with the use of 
representative Digital Imaging and Communications in 
Medicine images.
For analysis of the US images, participants were asked 
to assess the thyroid nodules according to the criteria 
from published literature (11, 12, 14-21). The criteria 
used in analysis included size (equal or larger than 5 mm), 
composition, echogenicity of solid portion, orientation, 
shape, margin, and calcifications. Composition of a nodule 
was categorized according to the ratio of the cystic portion 
to the solid portion in the nodule: solid (≤ 10% cystic), 
predominantly solid (> 10% cystic and ≤ 50% cystic), 
predominantly cystic (> 50% cystic) and spongiform 
appearance. A spongiform appearance was defined as 
the aggregation of multiple microcystic components 
consisting more than 50% of total volume of the nodule 
(11). Echogenicity of the solid portion was classified as 
hyper- or isoechogenicity, hypoechogenicity, or marked 
hypoechogenicity. When the echogenicity of the nodule 
was similar to the surrounding thyroid parenchyma, it was 
classified as isoechogenicity. Marked hypoechogenicity was 
defined as decreased echogenicity compared to the strap 
muscles (16). Orientation was categorized as non-parallel 
(greater in its anteroposterior dimension than transverse 
dimension) or parallel. Shape of the nodule was categorized 
as ovoid to round (when the anteroposterior diameter 
of the nodule was equal to or less than its transverse 
diameter on a transverse or longitudinal plane) and 
irregular (when a nodule was not ovoid to round). Margins 
were classified as well-defined smooth, microlobulated 
or spiculated, or ill-defined (11). Calcifications were 
categorized as microcalcifications, macrocalcifications, or 
none. Microcalcifications were defined as calcifications that 
were equal to or less than 1 mm in diameter, which was 
visualized as tiny, punctate hyperechoic foci, either with or 
without acoustic shadows. If tiny bright reflectors with a 
clear-cut comet-tail artifact were present on conventional 
US, we considered these as colloid. Macrocalcifications were 
defined as hyperechoic foci larger than 1 mm, including 
rim or eggshell calcifications. When the nodules had both 
types of calcifications (macrocalcifications including rim 
calcifications intermingled with microcalcifications), the 
nodule was considered to have microcalcifications.
Data and Statistical Analysis
The statistical analyses of this study consisted of 3 steps. 
First, the association between gender and malignancy 
using the chi-square test, and the association between 
patient age or nodule size and malignancy using an 
independent two-sample t test was evaluated in all the 
included patients. Following this, a statistician (J. I.) 
randomly selected a subset of 1402 nodules from 1260 
patients to constitute a training model among the 2000 
nodules. The remaining 598 nodules in 536 patients were 
used as a test set for validation of the training model. The 
second step was to evaluate the malignancy risk of the 
independent US features using multiple logistic regression 
analysis after controlling for all US features, and to get a 
predicted probability from the analysis. Odds ratios (ORs) 
and 95% confidence intervals (CIs) of each US feature were 
calculated. For risk score analyses, ORs for each US feature 
from the final logistic regression model was used. All ORs 
were standardized to make the scores approach an integer 
- 1 and to make it easier to use. The lowest value was 0, 
which indicated that US features were not to predictive of 
malignancy. The risk score for each nodule was obtained 
by summing the scores of each of suspicious US feature. 
At the next step, we established a diagnostic prediction 
model to estimate the malignant risk of thyroid nodules, 
using suspicious malignant US features in the training 
set for model building. The final step was to validate the 
prediction model from the training set using the test set. 
Here, we evaluated the diagnostic performances, as well as 
the predicted probability of the test set. We calculated the 
area under the receiver operating characteristic (ROC) curve 
(Az) with 95 % confidence interval (CI) using the US risk 
score for both the training and test sets. 
Analysis was performed using the SAS software (version 
9.2; SAS Institute, Cary, NC, USA). Statistical significance 
was assumed when the p value was less than 0.05. All 
reported p values are 2-sided.
RESULTS
The pathologic diagnoses of 732 thyroid cancers are 
listed in Table 1. The mean size of the benign nodules were 
17.3 ± 11.7 mm, which was significantly larger than that 
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of malignant nodules, 10.9 ± 8 mm (p < 0.001). Patients 
with malignant nodules (49 ± 12.3 years) were significantly 
younger than those with benign nodules (50.5 ± 11.9 years, 
p = 0.01). There was no statistically significant relationship 
between the gender and malignancy. 
Model Building Using Training Data Set
The association between US features and malignancy is 
summarized in Table 2. On multiple regression analysis, 
hypoechogenicity, marked hypoechogenicity, non-parallel 
orientation, microlobulated or spiculated margin, ill-defined 
margin, microcalcifications were US features showing 
statistical significance. Microlobulated or spiculated margin 
and marked hypoechogenicity showed high OR of greater 
than 5, respectively. Table 3 shows the malignancy rate 
according to the US risk score. Malignancy rates were 7.3 
in thyroid nodules with no suspicious US feature. Among 
each suspicious US feature, malignancy rates were 8.3 in 
thyroid nodules with either non-parallel orientation or ill-
defined margin, 59.1 in thyroid nodules with microlobulated 
or spiculated margin, and 43.6 in thyroid nodules with 
marked hypoechogenicity. The malignancy rate was higher 
in the thyroid nodule showing suspicious malignant US 
features with a high OR, such as marked hypoechogenicity, 
microlobulated or spiculated margin than one with two 
or more suspicious malignant US features with low OR 
Table 1. Histopathologic Results of 732 Malign
Histopathologic Result Number Percentage
Papillary carcinoma
Conventional 686 93.7
Follicular variant 18 2.5
Diffuse sclerosing variant 4 0.6
Solid variant 1 0.1
Hurthle cell variant 1 0.1
Follicular carcinoma 
Not described about subtype 8 1.1
Minimally invasive 4 0.6
Medullary carcinoma 8 1.1
Anaplastic carcinoma 1 0.1
Lymphoma 1 0.1
Table 2. Association Between Thyroid Malignancy and Various Sonographic Features at Thyroid Nodules of Training Data Set on 
Multiple Logistic Regression and Risk Score Analysis
Malignant (n = 523) Benign (n = 879) P* Odds Ratio (95% CI)† P‡ Risk Score§
Composition < 0.001
Solid 477 (46.1) 557 (53.9) 2.697 (0.925, 7.864) 0.069 0
Predominantly solid (< 50% cystic) 18 (11.6) 137 (88.4) 1.508 (0.463, 4.915) 0.496 0
Predominantly cystic (≥ 50% cystic) 24 (15.2) 134 (84.8) 2.232 (0.704, 7.073) 0.173 0
Spongiform appearance 4 (7.3) 51 (92.7) 1.000 (reference) 0
Echogenicity < 0.001
Hyper/Isoechogenicity 55 (10.7) 460 (89.3) 1.00 (reference) 0
Hypoechogenicity 286 (43.5) 371 (56.5) 2.602 (1.812, 3.737) < 0.001 2
Marked hypoechogenicity 182 (79.1) 48 (20.9) 6.814 (4.149, 11.189) < 0.001 6
Orientation   < 0.001
Non-parallel 252 (71.2) 102 (28.8) 2.337 (1.647, 3.317) < 0.001 1
Parallel 271 (25.9) 777 (74.1) 1.000 (reference) 0
Shape < 0.001
Ovoid to round 355 (30.3) 816 (69.7) 1.00 (reference) 0
Irregular 168 (72.7) 63 (27.3) 1.325 (0.834, 2.105) 0.234 0
Margin < 0.001
Well-defined smooth 137 (17) 670 (83) 1.00 (reference) 0
Microlobulated or spiculated 319 (79.8) 81 (20.3) 5.998 (4.132, 8.708) < 0.001 5
Ill-defined 67 (34.4) 128 (65.6) 1.634 (1.06, 2.519) 0.026 1
Calcifications < 0.001
Microcalcifications 239 (63.6) 137 (36.4) 3.345 (2.402, 4.659) < 0.001 2
Macrocalcifications 76 (37.3) 128 (62.7) 1.138 (0.756, 1.711) 0.536 0
No calcifications 208 (25.3) 614 (74.7) 1.00 (reference) 0
Note.— *By chi-square test, †,‡By multiple logistic regression analysis, §To create a risk score, reference categories for each ultrasound 
feature are those that had lowest rate of benignity. Each category is compared to assigned reference group to calculate odds ratio of 
thyroid malignancy. Risk score was calculated as nearest integer - 1. CI = confidence interval, number in parenthesis is percent.
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such as hypoechogenicity, non-parallel orientation, ill-
defined margin, and microcalcifications. The malignancy 
rate was highest, 95.2, in a thyroid nodule showing marked 
hypoechogenicity, non-parallel orientation, microlobulated 
or spiculated margin, and microcalcifications. The predicted 
probability of malignancy tended to rise along with the risk 
score (Fig. 1A). Area under the ROC curve was 0.867 (95% 
CI, 0.846-0.887; Fig. 2A), which shows that the US risk 
score predicts thyroid malignancy well. 
Model Validation 
Among the 598 nodules in 536 patients used as a test 
set, the malignancy rate was 6.2 in thyroid nodules with 
no suspicious US feature. The malignancy rate was 8.6 in 
thyroid nodules with either non-parallel orientation or ill-
defined margin, 33.3 in thyroid nodules with microlobulated 
or spiculated margin, and 34.5 in thyroid nodules with 
marked hypoechogenicity (Table 3). The predicted 
probability of malignancy also tended to rise along with the 
US risk scores (Fig. 1B). The Az value of the test set was 
0.872 (95% CI, 0.841-0.903; Fig. 2B) using the prediction 
model.
DISCUSSION
Until now, 3 TIRADS systems (5-7) and one 5-point 
malignancy rating scale system (8) have been developed 
in reporting thyroid nodules using US. The first one 
was constructed using standardized 10 US patterns and 
correlated the malignancy risk of the US patterns (5). 
Fig. 1. Scatter plots of predicted probability by total score. Predicted probability of malignancy tended to increase as risk score increased 
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Fig. 2. Receiver operating characteristic (ROC) curves for training and validation data set based on risk scores from logistic 
regression model. 
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Horvath et al’s study seems simple, but it has limitations in 
that too many US features should be converted into these 
stereotypic 10 US patterns to assume their malignancy 
risk, which sometimes is difficult to do. Park et al. (6) 
presented with the TIRADS system, which was established 
using multiple logistic regression analysis. The resulting 
equation may be accurate, but is a very complex process if 
applied during daily practice. To make it easier and more 
applicable, the number of suspicious malignant US features 
was calculated in Kwak et al. (7). The main limitation of 
Kwak et al’s study was that each suspicious US feature was 
summed as the same weight, even though each US feature 
has a different probability of malignancy. Therefore, the 
risk of malignancy was higher in a thyroid nodule with 
one suspicious US feature, such as a microcalcification or 
microlobulated margin than for a thyroid module with 2 
suspicious malignant US features (solid composition and 
hypoechogenicity). Hambly et al. (8) was based on the 
observer’s experience alone, not on the analysis of specific 
US features, therefore, failing to function as a concrete 
guideline for thyroid nodules. 
To overcome the shortcomings of the previous studies, we 
have established a simple diagnostic prediction model using 
US features of thyroid nodules based on a multicenter data 
collected retrospectively. In this study, each suspicious US 
feature had a different risk score according to their ORs in 
thyroid malignancy. Using the prediction model proposed in 
this study, we can obtain the risk of malignancy in thyroid 
nodules by the calculated total score, which is comparable 
to previous studies (Table 4). Similar to BI-RADS used in 
breast nodules, TIRADS should provide a proper guideline 
in deciding whether to perform FNA or not in a thyroid 
nodule. All TIRADS recommend performing FNA in a thyroid 
nodule categorized as 4 or 5. The risk of malignancy was 
6.2% among category 3 nodules in this study, which was 
lower than those of Horvath et al. and Park et al. (14.1% 
and 31.1%, respectively) (5, 6), however, similar to Hambly 
et al. (4.3-8%) (8), and higher than Kwak et al. (1.5%) 
(7). Like the previous studies in which risk of malignancy 
increased proportionally to the number of suspicious 
malignant US features, this study shows the tendency of 
increased predicted probability of malignancy along with 
the increase of risk scores. In this study, we calculated 
the area under the curve of a validation data set to assess 
the accuracy of predicting thyroid malignancy, using the 
prediction model derived from a total risk score. The value 
was 0.872, which was similar to those of Hambly et al. 
(8) (0.794-0.904) where results were calculated among 7 
radiologists with different levels of experience.
Although the American College of Radiology (ACR) 
recommends a specific malignancy risk range in breast 
lesions according to each assessment category of BI-RADS, 
we still do not have an established guideline proposing 
a specific malignant risk that can be used to safely avoid 
FNA in a thyroid nodule. TIRADS is similar to BI-RADS, 
but the malignant risk cannot be used as an identical 
concept, since the clinical aggressiveness is unquestionably 
different between breast and thyroid cancer. Considering 
the previously established TIRADS (5-8), the results of this 
multicenter study suggests a new approach in malignant risk 
stratification in a thyroid nodule within the proper range of 
malignancy risk, as well as complementing the limitations 
of the complexity of TIRADS.
This study has several limitations. First, selection bias 
may have existed when choosing patients to enroll in this 
study. Some patients who had not undergone follow-up after 
being confirmed as benign on cytology or when they had 
not undergone surgery after malignant cytology results were 
not included in this study. Second, we regarded the nodules, 
which were benign on initial cytology and stable for at least 
a year as benign. False-negative results may have existed 
among the cytology results (22-25), which may have had 
effect on our results. Third, interobserver variability in 
Table 3. Malignancy Rate of Malignancy by Total Score on 
Multiple Logistic Regression Model in Training and Validation 
Data Set











0 343 7.3 0 145 6.2
1 84 8.3 1 35 8.6
2 277 15.5 2 124 12.9
3 87 28.7 3 48 31.3
4 95 31.6 4 27 29.6
5 44 59.1 5 15 33.3
6 39 43.6 6 29 34.5
7 68 58.8 7 33 60.6
8 96 77.1 8 41 80.5
9 69 85.5 9 19 79
10 46 87 10 16 93.8
11 24 79.2 11 12 83.3
12 59 84.8 12 21 95.2
13 29 96.6 13 13 92.3
14 42 95.2 14 20 90
Note.— *Sum of all scores of individual items
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interpretations of US images among the 20 radiologists 
were not evaluated. Furthermore, radiologists involved in 
this study had more than 5 years of experiences in thyroid 
imaging; therefore, the results of other institutions may 
not be reproducible as in our study. Fourth, the malignancy 
rate of thyroid nodules included in this study was relatively 
high, 36.6%, comparing to those of other studies (9.2-
13%) (14, 26). The high prevalence of malignancy in this 
study may affect the malignancy rate of each risk score in 
this study. Fifth, we did not evaluate the US features that 
are suggestive of benign nodules. A spongiform appearance 
in a thyroid nodule was represented as a benign features 
in previous studies, with a nearly 100% positive predictive 
value (11, 27). However, the malignancy rate of thyroid 
nodules with spongiform appearance was 7.3% in our study, 
which was in contrast with previous reports. Interobserver 
variability during interpretation of US features may have 
lead to this discrepant result (3).
In conclusion, the predictor model from this multicenter 
data using suspicious malignant US features may be helpful 
in risk stratification in a thyroid nodule.
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